180 related articles for article (PubMed ID: 37325521)
1. Co-delivery of a tumor microenvironment-responsive disulfiram prodrug and CuO
Cheng FT; Geng YD; Liu YX; Nie X; Zhang XG; Chen ZL; Tang LQ; Wang LH; You YZ; Zhang L
Nanoscale Adv; 2023 Jun; 5(12):3336-3347. PubMed ID: 37325521
[TBL] [Abstract][Full Text] [Related]
2. A tumor microenvironment-responsive core-shell tecto dendrimer nanoplatform for magnetic resonance imaging-guided and cuproptosis-promoted chemo-chemodynamic therapy.
Ni C; Ouyang Z; Li G; Liu J; Cao X; Zheng L; Shi X; Guo R
Acta Biomater; 2023 Jul; 164():474-486. PubMed ID: 37040813
[TBL] [Abstract][Full Text] [Related]
3. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy.
Chen M; Huang Z; Xia M; Ding Y; Shan T; Guan Z; Dai X; Xu X; Huang Y; Huang M; Zhao C
J Control Release; 2022 Jan; 341():351-363. PubMed ID: 34856225
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species-activated self-amplifying prodrug nanoagent for tumor-specific Cu-chelate chemotherapy and cascaded photodynamic therapy.
Chen J; Tan X; Huang Y; Xu C; Zeng Z; Shan T; Guan Z; Xu X; Huang Z; Zhao C
Biomaterials; 2022 May; 284():121513. PubMed ID: 35398586
[TBL] [Abstract][Full Text] [Related]
5. Disulfiram-loaded metal organic framework for precision cancer treatment via ultrasensitive tumor microenvironment-responsive copper chelation and radical generation.
Zhang H; Zhang Q; Guo Z; Liang K; Boyer C; Liu J; Zheng Z; Amal R; Yun SLJ; Gu Z
J Colloid Interface Sci; 2022 Jun; 615():517-526. PubMed ID: 35152072
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Tumor-Specific Disulfiram Chemotherapy by
Wu W; Yu L; Jiang Q; Huo M; Lin H; Wang L; Chen Y; Shi J
J Am Chem Soc; 2019 Jul; 141(29):11531-11539. PubMed ID: 31251050
[TBL] [Abstract][Full Text] [Related]
7. Disulfiram-loaded CuO
Hu W; Yang L; Liao H; Sun D; Ouyang XK; Wang N; Yang G
J Colloid Interface Sci; 2024 Jun; 674():9-18. PubMed ID: 38908062
[TBL] [Abstract][Full Text] [Related]
8. Smart Tumor Microenvironment-Responsive Nano-Prodrug for Disulfiram Toxification In Situ and the Exploration of Lethal Mechanisms in Cells.
Zhang Y; Qi G; Qu X; Wang B; Ma K; Jin Y
Langmuir; 2022 Jan; 38(1):584-592. PubMed ID: 34971310
[TBL] [Abstract][Full Text] [Related]
9. Self-supplying Cu
Gao Y; Cai X; Zou W; Tang X; Jiang L; Hao J; Zheng Y; Ye X; Ying T; Li A
RSC Adv; 2024 Apr; 14(19):13180-13189. PubMed ID: 38655468
[TBL] [Abstract][Full Text] [Related]
10.
Hou L; Liu Y; Liu W; Balash M; Zhang H; Zhang Y; Zhang H; Zhang Z
Acta Pharm Sin B; 2021 Jul; 11(7):2016-2030. PubMed ID: 34386335
[TBL] [Abstract][Full Text] [Related]
11. A cascade nanoplatform for intelligent response to tumor microenvironment and collaborative cancer therapy.
Li T; Rong M; Wang Y; Sun W; Lu L
J Mater Chem B; 2024 Mar; 12(10):2537-2546. PubMed ID: 38345306
[TBL] [Abstract][Full Text] [Related]
12. Disulfiram loaded calcium phosphate nanoparticles for enhanced cancer immunotherapy.
Li Q; Chao Y; Liu B; Xiao Z; Yang Z; Wu Y; Liu Z
Biomaterials; 2022 Dec; 291():121880. PubMed ID: 36334355
[TBL] [Abstract][Full Text] [Related]
13. ROS-triggered cycle amplification effect: A prodrug activation nanoamplifier for tumor-specific therapy.
Huang Z; Ding Y; Luo Y; Chen M; Zeng Z; Zhang T; Sun Y; Huang Y; Zhao C
Acta Biomater; 2022 Oct; 152():367-379. PubMed ID: 36084924
[TBL] [Abstract][Full Text] [Related]
14. Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents.
Kannappan V; Ali M; Small B; Rajendran G; Elzhenni S; Taj H; Wang W; Dou QP
Front Mol Biosci; 2021; 8():741316. PubMed ID: 34604310
[TBL] [Abstract][Full Text] [Related]
15. Two birds with one stone: Copper metal-organic framework as a carrier of disulfiram prodrug for cancer therapy.
Pan Q; Xie L; Liu R; Pu Y; Wu D; Gao W; Luo K; He B
Int J Pharm; 2022 Jan; 612():121351. PubMed ID: 34883206
[TBL] [Abstract][Full Text] [Related]
16. Copper-Enriched Prussian Blue Nanomedicine for In Situ Disulfiram Toxification and Photothermal Antitumor Amplification.
Wu W; Yu L; Pu Y; Yao H; Chen Y; Shi J
Adv Mater; 2020 Apr; 32(17):e2000542. PubMed ID: 32162734
[TBL] [Abstract][Full Text] [Related]
17. Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers.
Chen W; Yang W; Chen P; Huang Y; Li F
ACS Appl Mater Interfaces; 2018 Dec; 10(48):41118-41128. PubMed ID: 30444340
[TBL] [Abstract][Full Text] [Related]
18. A disulfiram/copper gluconate co-loaded bi-layered long-term drug delivery system for intraperitoneal treatment of peritoneal carcinomatosis.
Wang P; Luo Q; Zhang L; Qu X; Che X; Cai S; Liu Y
Colloids Surf B Biointerfaces; 2023 Nov; 231():113558. PubMed ID: 37776774
[TBL] [Abstract][Full Text] [Related]
19. Nanomedicine Enables Drug-Potency Activation with Tumor Sensitivity and Hyperthermia Synergy in the Second Near-Infrared Biowindow.
Liu W; Xiang H; Tan M; Chen Q; Jiang Q; Yang L; Cao Y; Wang Z; Ran H; Chen Y
ACS Nano; 2021 Apr; 15(4):6457-6470. PubMed ID: 33750100
[TBL] [Abstract][Full Text] [Related]
20. A tumor microenvironment-activated metal-organic framework-based nanoplatform for amplified oxidative stress-induced enhanced chemotherapy.
Li B; Yao X; Li J; Lu X; Zhang W; Duan W; Tian Y; Li D
J Biol Chem; 2023 Jan; 299(1):102742. PubMed ID: 36435198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
